SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-207669
Filing Date
2021-07-02
Accepted
2021-07-02 16:31:40
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d176924ds3.htm S-3 451776
2 EX-4.4 d176924dex44.htm EX-4.4 316646
3 EX-4.6 d176924dex46.htm EX-4.6 96106
4 EX-4.7 d176924dex47.htm EX-4.7 97532
5 EX-4.8 d176924dex48.htm EX-4.8 85653
6 EX-5.1 d176924dex51.htm EX-5.1 27443
7 EX-23.1 d176924dex231.htm EX-23.1 2160
8 GRAPHIC g176924g43e55.jpg GRAPHIC 35704
9 GRAPHIC g176924g53k34.jpg GRAPHIC 3688
  Complete submission text file 0001193125-21-207669.txt   1128541
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-257661 | Film No.: 211070645
SIC: 2834 Pharmaceutical Preparations